What are INDmoney investors doing with Aurobindo Pharma shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-19%
Searches for Aurobindo Pharma on INDmoney have decreased by 19% over the last 30 days.
Investment activity on INDmoney
+55.81%
Investment activity in Aurobindo Pharma among INDmoney users has increased by 55.81% over the last 30 days.
Among the most traded stocks
118th
Aurobindo Pharma was the 118th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
30 days
INDmoney investors hold Aurobindo Pharma shares for an average of 30 days.
Key Events for Aurobindo Pharma
Aurobindo Pharma Stock Performance
as on November 18, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,788.70₹1,817.40
0.42%
Downside
1.17%
Upside

52 Week's Low
52 Week's High
₹1,106.00₹1,859.90
38.43%
Downside
3.54%
Upside

Aurobindo Pharma share price movements today
- Previous Close
- ₹1,794.10
- Open
- ₹1,793.60
- Volume
- 11.92L
- Upper Circuit
- ₹1,850.10
- Lower Circuit
- ₹1,742.50
- Day's Low - High
- ₹1,788.70 - ₹1,817.40
- 52 Week Low - High
- ₹1,106.00 - ₹1,859.90
Aurobindo Pharma Historical Returns
- 1 Month Return
- + 10.65 %
- 3 Month Return
- + 9.06 %
- 1 Year Return
- + 44.77 %
- 3 Year Return
- + 79.75 %
- 5 Year Return
- + 180.53 %
Aurobindo Pharma Fundamentals
as on November 18, 2026 at 4:01 pm IST
Market Cap
₹1,03,228.55 Cr
Return on Equity (ROE)
11.17
PE Ratio (TTM)
26.02
Return on capital employed (ROCE)
12.91
Industry PE ratio
53.94
Beta (LTM)
0.43
P/B Ratio
3.33
Dividend Yield
0.31
PEG Ratio
2.59
Quarterly Earnings Growth YOY
32.51
EPS (TTM)
60.31
Book Value
652.39
Aurobindo Pharma Stock Valuation
as on November 18, 2026 at 4:01 pm IST
Aurobindo Pharma in the last 5 years
Lowest (6.73x)
March 23, 2020
Today (26.02x)
November 17, 2026
Industry (53.94x)
November 17, 2026
Highest (27.59x)
December 21, 2023
Today’s Price to Earnings Ratio: 26.02x
Aurobindo Pharma Technical Analysis
Track how Aurobindo Pharma technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.78 | Bullish |
CCI (20) | 18.33 | Neutral |
RSI (14) | 57.13 | Neutral |
Momentum (10) | 0 | Neutral |
ADI (14) | 50.42 | Neutral |
Ultimate Oscillator (7,14,28) | 90.5 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1798.73 | Bullish |
EMA (20) | 1798.87 | Bullish |
VWMA (20) | 1799.36 | Bullish |
SMA (50) | 1797.52 | Bullish |
EMA (50) | 1798.55 | Bullish |
SMA (200) | 1804.58 | |
EMA (200) | 1801.83 | |
KAMA (200) | 1797.29 | Bullish |
DEMA (200) | 1800.29 |
Aurobindo Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,03,228.55 | 36.11% | 0.60 | 3,502 | 33,653 | |
| BUY | 7,424.64 | -12.11% | 0.00 | 326 | 1,837 | |
| BUY | 1,20,119.41 | 32.06% | 0.69 | 5,026 | 51,180 | |
| BUY | 54,856.88 | 6.34% | 0.00 | 1,414 | 6,445 | |
| BUY | 45,529.57 | 12.78% | 0.56 | 1,035 | 3,821 |
Market expectation of Aurobindo Pharma Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
61.54%
Buy
19.23%
Hold
19.23%
Sell
Aurobindo Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Aurobindo Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Aurobindo Pharma Ltd Cash Flow
Figures in Rupees Crores
Aurobindo Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Aurobindo Pharma.
Aurobindo Pharma Ltd Earnings Results
Aurobindo Pharma Ltd’s net profit jumped 32.72% since last year same period to ₹1,126.08Cr in the Q2 2026-2027. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 9.06% jump in its net profits since last 3-months.
Read MoreAurobindo Pharma Ltd Dividends November,2026
In the quarter ending September 2026, Aurobindo Pharma Ltd has declared dividend of ₹7.00 per share on 04 Nov 2026 - translating a dividend yield of 0.39%.
Read More about Dividends
Indices Featuring Aurobindo Pharma Stock
Check stock indices that include Aurobindo Pharma.
Insights on Aurobindo Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 16.38% to 17.41% in Sep 2026 quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 6 quarters, 824.75 Cr → 1.12K Cr (in ₹), with an average increase of 6.0% per quarter
POSITIVE IMPACTPrice Rise

In the last 1 month, AUROPHARMA stock has moved up by 10.7%
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 6 quarters, 7.97K Cr → 10.43K Cr (in ₹), with an average increase of 5.2% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 535.2% return, outperforming this stock by 455.5%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 51.88% of holdings in Sep 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 132.2% return, outperforming this stock by 87.4%
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 16.71% to 16.31% in Sep 2026 quarter
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 6.64% to 6.29% in Sep 2026 quarter
Aurobindo Pharma Stock Futures & Options Contracts
View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.
Aurobindo Pharma Options
Aurobindo Pharma Futures
About Aurobindo Pharma Ltd
The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.
Revenue: ₹10,227.28Cr as on September 2026 (Q2 FY27)
Net Profit: ₹1,123.84Cr as on September 2026 (Q2 FY27)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
| Organisation | Aurobindo Pharma Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | K Ragunathan |
| E-voting on shares | Click here to vote |
FAQs
What is Aurobindo Pharma share price today?
Aurobindo Pharma share price today stands at ₹1796.3 as on at the close of the market. Aurobindo Pharma share today touched a day high of ₹1817.4 and a low of ₹1788.7.
What is the 52 week high and 52 week low range for Aurobindo Pharma share?
Aurobindo Pharma touched a 52 week high of ₹1859.9 and a 52 week low of ₹1106. Aurobindo Pharma share price today i.e. is closed at ₹1796.3, which is -3.42% down from its 52 week high and 62.41% up from its 52 week low.
What is Aurobindo Pharma's market capitalisation today?
Aurobindo Pharma market capitalisation is ₹1,03,228.55 Cr as on .
How to buy Aurobindo Pharma shares?
To buy Aurobindo Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Aurobindo Pharma trading volume today?
Aurobindo Pharma trading volume is 11.92L as on . This means that 11.92L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Aurobindo Pharma shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest in Aurobindo Pharma has decreased while investment activity has increased over the past 30 days, and the average INDmoney investor holds the stock for 30 days. This reflects platform activity only and is not investment advice.